ARP Rheumatology

Scope & Guideline

Unlocking Innovations in Rheumatic Disease Understanding

Introduction

Immerse yourself in the scholarly insights of ARP Rheumatology with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguagePortuguese
ISSN2795-4552
PublisherSociedade Portuguesa Reumatologia
Support Open AccessNo
CountryPortugal
TypeJournal
Convergefrom 2022 to 2024
AbbreviationARP RHEUMATOL / ARP Rheumatol.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressAvenida de Berlim, N 33B, Lisboa 1800-033, PORTUGAL

Aims and Scopes

ARP Rheumatology focuses on advancing knowledge and clinical practice in the field of rheumatology through a variety of research methodologies, including clinical studies, case reports, systematic reviews, and guidelines. The journal aims to provide valuable insights for practitioners and researchers alike.
  1. Clinical Management of Rheumatic Diseases:
    The journal emphasizes studies that provide evidence-based recommendations and clinical management strategies for various rheumatic conditions, ensuring the optimization of patient care.
  2. Patient-Reported Outcomes and Experiences:
    There is a consistent focus on understanding the patient perspective through the development and validation of patient-reported outcome measures, which are crucial for assessing treatment effectiveness and patient satisfaction.
  3. Innovative Therapeutic Approaches:
    ARP Rheumatology explores new therapeutic approaches, including biologic and biosimilar therapies, and their implications in the management of rheumatic diseases.
  4. Epidemiological Studies:
    The journal publishes epidemiological research that assesses the prevalence, characteristics, and outcomes of rheumatic diseases, contributing to a better understanding of these conditions in diverse populations.
  5. Multidisciplinary and Collaborative Research:
    The journal encourages collaboration across disciplines, highlighting studies that integrate various fields such as immunology, rheumatology, and pharmacology to address complex clinical questions.
ARP Rheumatology has identified several trending and emerging themes that reflect the evolving landscape of rheumatology research, particularly in response to contemporary challenges and advancements.
  1. Impact of COVID-19 on Rheumatic Diseases:
    Recent publications highlight the effects of COVID-19 on patients with rheumatic diseases, including complications and management strategies, reflecting the ongoing relevance of this global health crisis.
  2. Telemedicine and Remote Patient Monitoring:
    The rise of telemedicine and digital health solutions in managing rheumatic diseases is gaining attention, with studies focusing on the implications for patient care and accessibility.
  3. Personalized Medicine and Targeted Therapies:
    There is an increasing focus on personalized medicine approaches, particularly the use of targeted therapies and biologics, which are tailored to individual patient profiles and disease characteristics.
  4. Comorbidities and Multidisciplinary Care:
    Research is trending towards understanding the interplay between rheumatic diseases and comorbid conditions, emphasizing the importance of a multidisciplinary approach to patient management.
  5. Health-Related Quality of Life Measures:
    The use of validated health-related quality of life measures is becoming more prominent, reflecting a growing recognition of the importance of patient-centered care and outcomes.

Declining or Waning

While ARP Rheumatology has maintained a robust focus on various areas within rheumatology, certain themes have shown a decline in prominence in recent publications.
  1. Traditional Pharmacological Treatments:
    There has been a noticeable decrease in the publication of studies solely focusing on traditional pharmacological treatments for rheumatic diseases, as the field shifts towards biologics and personalized medicine.
  2. Rare Disease Case Reports:
    The frequency of case reports on rare rheumatic diseases appears to be waning, possibly due to a growing focus on more prevalent conditions and their management.
  3. Basic Science and Pathophysiology Studies:
    Research centered on basic science and underlying pathophysiological mechanisms of rheumatic diseases has seen reduced representation, with more emphasis placed on clinical applications and patient outcomes.

Similar Journals

Pediatric Rheumatology

Championing excellence in pediatric rheumatology research and practice.
Publisher: BMCISSN: Frequency: 1 issue/year

Pediatric Rheumatology is a leading peer-reviewed open access journal published by BMC, dedicated to disseminating high-quality research in the field of pediatric rheumatology. Since its inception in 2007, the journal has established itself as a vital resource for healthcare professionals, researchers, and students focused on pediatric immunology, rheumatology, and child health, maintaining an impressive Q1 ranking in Pediatrics and Q2 in Immunology and Allergy as well as Rheumatology for 2023. It is recognized for its impact on advancing knowledge and clinical practice, with significant contributions noted in various studies and case reports. With access options that embrace the ethos of open science, all articles published in Pediatric Rheumatology are freely available, promoting collaborative research and discussion among practitioners across the globe. The journal welcomes submissions that encapsulate innovative research, clinical trials, and reviews that address both current challenges and advancements within the pediatric rheumatology landscape.

International Journal of Rheumatic Diseases

Bridging research and clinical practice in rheumatology.
Publisher: WILEYISSN: 1756-1841Frequency: 12 issues/year

The International Journal of Rheumatic Diseases, published by WILEY, serves as a crucial platform for disseminating high-quality research and advancements in the field of rheumatology. With an ISSN of 1756-1841 and an E-ISSN of 1756-185X, this journal has established itself within the academic community since its inception in 2008, and it is set to continue until at least 2024. Positioned in the Q3 category of rheumatology, the journal holds a significant rank of #38 out of 73 in its field according to Scopus, showcasing its growing influence despite the competitive environment. The absence of Open Access reflects a traditional scholarly publishing model, allowing for meticulous peer-review processes to ensure the rigor and reliability of published studies. This journal aims to foster innovative research, critical reviews, and clinical studies, thereby contributing to a deeper understanding of rheumatic diseases and enhancing patient care. The dedicated readership, including researchers, healthcare professionals, and students, will find valuable insights into the latest findings and methodologies relevant to rheumatology in the journal's comprehensive articles.

JOURNAL OF INTERNAL MEDICINE

Shaping the Future of Internal Medicine
Publisher: WILEYISSN: 0954-6820Frequency: 12 issues/year

The JOURNAL OF INTERNAL MEDICINE, a prestigious publication in the field of Internal Medicine, is published by WILEY and ranks among the top journals in its category, holding a remarkable Q1 designation in the 2023 Scopus Rankings. With its ISSN 0954-6820 and E-ISSN 1365-2796, this journal has garnered a significant impact within the medical community, being ranked 7th out of 167 in the field and maintaining a remarkable 96th percentile ranking. The journal covers a broad spectrum of research topics relevant to internal medicine, providing vital insights that advance clinical practices and enhance patient care. Since its inception in 1989, the JOURNAL OF INTERNAL MEDICINE has established itself as an essential resource for researchers, healthcare professionals, and students, facilitating the dissemination of groundbreaking studies and fostering academic discourse. Despite its traditional access model, the journal's commitment to high-quality research remains unwavering, making it a cornerstone in the field of Internal Medicine.

European Journal of Rheumatology

Elevating Standards in Rheumatology Scholarship
Publisher: AVESISSN: 2147-9720Frequency: 4 issues/year

European Journal of Rheumatology is a premier, peer-reviewed journal that has been paving the way for innovative research and in-depth analysis in the field of rheumatology since its launch. Published by AVES, this Open Access journal has been accessible to researchers, professionals, and students worldwide since 2014, promoting the sharing of valuable knowledge on rheumatic diseases and their treatment. With an ISSN of 2147-9720 and an E-ISSN of 2148-4279, it provides a prominent platform for groundbreaking studies and clinical evaluations that bridge scientific discovery with practical application. The journal’s mission is to enhance the understanding of rheumatological conditions and facilitate advancements in therapeutic strategies, making it an essential resource for anyone devoted to the improvement of patient care in this dynamic field. The European Journal of Rheumatology is committed to upholding the highest standards of scholarly publishing and aims to foster collaboration among researchers and practitioners across Europe and beyond.

Rheumatology Advances in Practice

Empowering rheumatology through innovation and education.
Publisher: OXFORD UNIV PRESSISSN: Frequency: 2 issues/year

Rheumatology Advances in Practice, published by Oxford University Press, is a vital open-access journal dedicated to advancing research and education in the field of rheumatology. With an E-ISSN of 2514-1775 and an impressive open access model established since 2017, this journal facilitates the dissemination of cutting-edge knowledge and innovative practices to a global audience. It has garnered recognition within the academic community, holding a Q3 classification in Rheumatology for 2023, which reflects its contribution to the evolving landscape of rheumatological research. The journal aims to present high-quality, peer-reviewed articles that explore the latest findings, advancements, and clinical applications in rheumatology, making it an essential resource for researchers, healthcare professionals, and students alike. By bridging the gap between research and practice, Rheumatology Advances in Practice plays a significant role in improving the care of patients with rheumatological conditions, promoting evidence-based approaches to clinical challenges.

Archives of Rheumatology

Advancing knowledge in rheumatology for a healthier future.
Publisher: TURKISH LEAGUE AGAINST RHEUMATISMISSN: Frequency: 4 issues/year

Archives of Rheumatology is a premier peer-reviewed journal dedicated to advancing the field of rheumatology through the dissemination of high-quality research, reviews, and case studies. Published by the Turkish League Against Rheumatism, this open-access journal provides a platform for researchers, clinicians, and students to share insightful findings and innovative approaches in the diagnosis and management of rheumatologic diseases. With the goal of promoting knowledge exchange on a global scale, the journal welcomes submissions that enhance understanding and foster advancements in the clinical and biological aspects of rheumatic conditions. Each publication contributes significantly to the growing body of literature in this vital field of medicine, making Archives of Rheumatology an essential resource for both established and emerging researchers looking to stay abreast of the latest developments and clinical practices.

Current Rheumatology Reviews

Pioneering insights for modern rheumatology.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-3971Frequency: 3 issues/year

Current Rheumatology Reviews is an esteemed journal dedicated to publishing comprehensive reviews on advancements in the field of rheumatology. Established by Bentham Science Publishers, this journal has become a vital resource for researchers, clinicians, and students seeking to stay abreast of the latest developments and therapeutic strategies from 2006 to 2024. Located in the United Arab Emirates, it caters to a global audience, delivering insights that have been pivotal in shaping clinical practices. With an impact factor reflective of its Q3 status in Rheumatology by 2023, the journal ranks #46 out of 73 in the Scopus database, positioning it in the 37th percentile in the discipline. Although it operates without open access, its high-quality content ensures that each article undergoes rigorous peer review, making the Current Rheumatology Reviews a trusted platform for disseminating critical research findings and reviews that drive forward the understanding and treatment of rheumatic diseases.

Reumatismo

Unveiling breakthroughs in rheumatic disease management.
Publisher: PAGEPRESS PUBLISSN: 0048-7449Frequency: 4 issues/year

Reumatismo is a distinguished Open Access journal dedicated to the field of rheumatology, published by PAGEPRESS PUBL since 2001. With a rich history dating back to 1952, this journal has been pivotal in disseminating vital research on rheumatic diseases and related disorders. Based in Italy, Reumatismo has earned a reputation for its quality and relevance, achieving a Q3 category ranking in the 2023 Scopus metrics for Rheumatology, reflecting its significant contributions to the field. The journal is committed to providing a platform for the latest scientific developments and clinical innovations, thus aiding researchers, healthcare professionals, and students striving to enhance understanding and treatment of rheumatic conditions. For those seeking to access comprehensive research articles and studies, Reumatismo boasts an open access policy, ensuring that knowledge is freely available to all, fostering collaboration and advancement in rheumatology worldwide.

Journal of Rheumatic Diseases

Empowering discovery through open-access rheumatology research.
Publisher: KOREAN COLL RHEUMATOLOGYISSN: 2093-940XFrequency: 4 issues/year

Journal of Rheumatic Diseases, published by the Korean College of Rheumatology, stands as a pivotal platform in the field of rheumatology, contributing significantly to the advancement of knowledge and clinical practice since its inception. With an impact factor reflecting its esteemed position in the academic community, this open-access journal promotes accessibility to high-quality research, ensuring that groundbreaking discoveries are reachable to all stakeholders in the realm of rheumatic diseases. The journal has maintained its commitment to quality, evidenced by its ranking in the Q3 category for Rheumatology in 2023, and its presence among the top quartiles of medical research. Focusing on innovative therapeutic approaches, emerging diagnostic techniques, and comprehensive reviews, the Journal of Rheumatic Diseases seeks to foster collaboration and dialogue among researchers, clinicians, and students alike. For accessibility, the journal offers numerous articles since its transition to open access in 2017, thereby facilitating research dissemination across the globe. As it converges over the years from 2019 to 2024, the journal promises to be instrumental in shaping the future of rheumatic disease research, inviting contributions that inspire new frontiers in this essential field.

CURRENT OPINION IN RHEUMATOLOGY

Advancing Knowledge in the Realm of Rheumatology
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1040-8711Frequency: 6 issues/year

Current Opinion in Rheumatology, published by Lippincott Williams & Wilkins, stands as a vital resource in the field of rheumatology. Since its inception in 1989, this prestigious journal has been at the forefront of disseminating cutting-edge research, with a notable Q1 ranking in the 2023 Rheumatology category and an impressive Scopus rank of 7 out of 73, placing it in the 91st percentile. The journal's commitment to presenting insightful reviews and critical analyses of recent advancements and treatment strategies makes it an essential read for professionals, researchers, and students dedicated to the study of rheumatic diseases. Although not an open-access journal, Current Opinion in Rheumatology continues to foster an informed dialogue within the academic community through its high-impact content, ensuring that the latest developments and practices are accessible to those at the vanguard of rheumatology research.